Shen, M., Sharma, A., Andersen, C., Nelson, J., Debreczeni, J., Hauke, P., Wu, M., Huang, Y., Dillman, K., Liang, H., Liu, Z., Tokheim, C., Seong, A., Chan, L., Moreau, K., Seneviratne, U., Singh, M., Quinn, T., Morrill, L., Davies, R., Gutierrez, P., Srivastava, A., Voulgarelis, D., Lamb, M., Saeh, J., Younes, A., Wilson, D., Fawell, S., Drew, L., Tavana, O. (2025). Development and characterization of a potent and selective BLIMP1 protac as a novel, first-in-class therapy for multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-2554